Invention Grant
- Patent Title: Nucleic acid based vaccine against middle east respiratory syndrome-coronavirus
-
Application No.: US17230383Application Date: 2021-04-14
-
Publication No.: US11305008B2Publication Date: 2022-04-19
- Inventor: Anwar M. Hashem
- Applicant: King Abdulaziz University
- Applicant Address: SA Jeddah
- Assignee: King Abdulaziz University
- Current Assignee: King Abdulaziz University
- Current Assignee Address: SA Jeddah
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/12 ; A61K39/215 ; A61K39/155 ; A61P31/14 ; C07K14/705 ; C12N15/62
Abstract:
An immunogenic CD40-targeted trimeric MERS-CoV S1 fusion polypeptide as well as a corresponding polynucleotide encoding it and its use for safely inducing immune responses directed against MERS-CoV without inducing vaccine associated respiratory pathologies associated with non-targeted vaccines.
Public/Granted literature
- US20220054629A1 NUCLEIC ACID BASED VACCINE AGAINST MIDDLE EAST RESPIRATORY SYNDROME-CORONAVIRUS Public/Granted day:2022-02-24
Information query
